Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 On August 6, 2008, the Drug Enforcement Administration (DEA) published a Notice of Application for Registration for Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409 in the 
                    **Federal Register**
                     pursuant to 21 CFR 1301.33(a) (73 FR 45784). On May 28, 
                    ( print page 53281)
                    2008, Chattem Chemicals Inc., had made application by renewal to DEA as a bulk manufacturer of the certain basic classes of controlled substances listed in schedules I and II. The Notice of Application published August 6, 2008, listed the following basic classes of controlled substances for which Chattem Chemicals Inc. sought registration as a bulk manufacturer: Drug
Schedule4-Methoxyamphetamine (7411)
IDifenoxin (9168)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIMethylphenidate (1724)
IIPentobarbital (2270)
IICodeine (9050)
IIOxycodone (9143)
IIHydrocodone (9193)
IIMeperidine (9230)
IIDextropropoxyphene, bulk (non-dosage forms) (9273)
IIMorphine (9300)
IIThebaine (9333)
IINoroxymorphone (9668)
IIAlfentanil (9737)
IISufentanil (9740)
IIFentanyl (9801)
II
 DEA inadvertently did not include the following substances for which Chattem Chemicals Inc. also seeks registration as a bulk manufacturer: Drug
ScheduleLisdexamfetamine Mesylate (1205)
IIDihydrocodeine (9120)
IIDihydromorphine (9145)
IIHydromorphone (9150)
IIOripavine (9330)
IIOxymorphone (9652)
IIReminfentanil (9739)
II
 The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152. As DEA inadvertently did not include all basic classes of controlled substances for which Chattem Chemicals Inc. sought registration in the Notice of Application published August 6, 2008, DEA is extending the comment period for this application in accordance with 21 CFR 1301.33(a). Therefore, the comment period for this application is extended from October 6, 2008 to November 14, 2008. Dated: September 8, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E8-21461 Filed 9-12-08; 8:45 am] BILLING CODE 4410-09-P